ARTHROLYSIS

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting ARTHROLYSIS:

# Drug Count
0 ANTIHEMOPHILIC FACTOR (RECOMBINANT) 2
1 VEMURAFENIB 1
See all common drugs associated with ARTHROLYSIS

ARTHROLYSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTIHEMOPHILIC FACTOR (RECOMBINANT) 2 0.0002
1 VEMURAFENIB 1 0.0001
See all drugs enriched for association with ARTHROLYSIS

These drug classes are most commonly taken by patients reporting ARTHROLYSIS:

# Drug class Count
0 Kinase Inhibitor [EPC] 1
See all common drug classes associated with ARTHROLYSIS

ARTHROLYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Kinase Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with ARTHROLYSIS